Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000078003-11-000012
Filing Date
2011-09-12
Accepted
2011-09-12 13:27:03
Documents
2
Period of Report
2011-09-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6280
2 EXHIBIT 99 ex99sig.htm EX-99.EXHIBIT 99 3744
  Complete submission text file 0000078003-11-000012.txt   12145
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34217 | Film No.: 111085344
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 4222 EMPEROR BLVD SUITE 350 DURHAM NC 27703 919-941-5206
ICAGEN INC (Issuer) CIK: 0000902622 (see all company filings)

EIN.: 561785001 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 235 EAST 42ND ST. MS 235/19/2 NEW YORK NY 10017
Business Address 235 EAST 42ND ST. MS 235/19/2 NEW YORK NY 10017 2127332323
Eclipse Acquisition Corp. (Reporting) CIK: 0001529320 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34217 | Film No.: 111085343